Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01858350
Other study ID # RC1AT005699
Secondary ID
Status Completed
Phase N/A
First received May 13, 2013
Last updated May 16, 2013
Start date August 2009
Est. completion date August 2012

Study information

Verified date May 2013
Source Wayne State University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The investigators conducted a prospective open unblinded clinical four-arm evaluation of Complementary and Alternate Medicine (CAM) interventions on children 1-12 years of age who were undergoing imaging by Medical Resonance Imaging(MRI) and receiving parenteral sedation. Children were assigned to active music therapy, passive music therapy, distraction therapy, and no intervention; measures included doses and numbers of sedation medications, time of sedation, and salivary levels of the stress hormone cortisol and pro-inflammatory cytokines, before and immediately after the intervention was completed. The Time Frame for the outcome measures are at the start of the intervention and immediately following the procedure (generally about 150 minutes). No further follow up was conducted.


Recruitment information / eligibility

Status Completed
Enrollment 471
Est. completion date August 2012
Est. primary completion date August 2012
Accepts healthy volunteers No
Gender Both
Age group 1 Year to 12 Years
Eligibility Inclusion Criteria:

- Children ages 1-12 years undergoing MRI studies

Exclusion Criteria:

- Patients with significant congenital anomalies, genetic syndromes and central nervous system malformations

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Active Music Therapy

Passive Music Therapy

Distraction Therapy


Locations

Country Name City State
United States Wayne State University and Children's Hospital of Michigan Detroit Michigan

Sponsors (1)

Lead Sponsor Collaborator
Wayne State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Need for sedation medications for MRI is reduced Intervention is performed prior to sedation. Following sedation, the patient undergoes MRI. After the MRI is completed, the amount of sedation given to the patient is recorded. No other follow up is required. The Time Frame for the outcome measures are at the start of the intervention and immediately following the procedure (average about 150 minutes). No further follow up was conducted. No
Secondary To measure the effect of the interventions on salivary cortisol and inflammatory cytokines The aim of this measure was to determine if the interventions changed the levels of salivary cortisol and inflammatory cytokines Saliva samples were collected before the intervention and then after the MRI was performed (average about 150 minutes). No
See also
  Status Clinical Trial Phase
Completed NCT01589289 - Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC Phase 3
Completed NCT00010881 - Oregon Center for Complementary and Alternative Medicine in Neurological Disorders N/A
Recruiting NCT04461821 - Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents
Completed NCT04094571 - Muscle Delay Characterization N/A
Completed NCT04072536 - Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving N/A
Recruiting NCT02795052 - Neurologic Stem Cell Treatment Study N/A
Completed NCT02219269 - A Complex Contraception Registry N/A
Completed NCT00122174 - Stress-Busting Program for Caregivers of Patients With Neruological Diseases N/A
Recruiting NCT01524276 - Product Surveillance Registry
Completed NCT00532571 - Effects of Coenzyme Q10 in PSP and CBD Phase 2/Phase 3
Completed NCT05830981 - Valproic Acid Use in Patients With Neurological Disorders
Completed NCT01754168 - Amyloid Beta and Cognition in Parkinson Disease N/A
Completed NCT02780531 - Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases
Suspended NCT05212727 - Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders
Recruiting NCT01266382 - The Effect of AposTherapy on the Level of Pain, Function and Quality of Life in Patients With Neuro-muscular and Neurological Disorders N/A